Synonyms: PF-3274167 | PF3274167
Compound class:
Synthetic organic
Comment: Cligosiban (PF-3274167) is an oxytocin receptor antagonist, with proposed action at central oxytocin receptors [3].
|
|
No information available. |
Summary of Clinical Use |
Pharmacokinetics, safety, and tolerability of cligosiban has been investigated in clinical studies [1-2]. The compound was developed for the treatment of premature ejaculation, but does not appear to be an active clinical lead for this indication in March 2024. |